PE Biosystems DNA Analyzer Demand, Strong Sales Boost Stock 26% In Q3
This article was originally published in The Gray Sheet
Executive Summary
Continued strong demand for the ABI Prism 3700 DNA analyzer, order growth across a broad range of additional products and release of financial results ahead of some analysts' estimates contributed to a 25.9% jump in PE Biosystems' stock price during the third quarter.